Dermatology
From the Journals
Watchful waiting in BCC: Which patients can benefit?
A study published in JAMA Dermatology sheds light on which patients with BCC may be appropriate candidates for watchful waiting.
News
FDA approves topical ruxolitinib for atopic dermatitis, first JAK inhibitor for this indication in the U.S.
“Approval of topical ruxolitinib fills a major gap in the treatment of atopic dermatitis: a safe, effective, and tolerable non-steroidal topical...
Conference Coverage
Skin ulcers can pose tricky diagnostic challenges
According to Dr. Alex G. Ortega-Loayza, there is a lack of gold-standard diagnostic criteria for atypical/inflammatory ulcers and a lack of...
From the Journals
Medicare patients’ cost burden for specialty psoriasis, PsA drugs remains high
Coverage of and access to biologics for psoriasis and psoriatic arthritis are compromised by out-of-pocket payments and prior authorization...
From the Journals
Novel diabetic foot ulcer cream shows promise in phase 3 trial
The first-in-class cream, which acts on macrophages, was better than a standard absorbent dressing for healing diabetic foot ulcers in a phase 3...
From the Journals
New guidance on preventing cutaneous SCC in solid organ transplant patients
Recommendations include cryotherapy as first-line therapy for actinic keratosis, with the exception of thin actinic keratoses grouped in one area...
From the Journals
Atopic dermatitis subtype worsens into midlife, predicting poor health
“A more comprehensive understanding of disease activity across the life span is needed,” the investigators wrote.
Latest News
FDA inaction on hair loss drug’s suicide, depression, erectile dysfunction risk sparks lawsuit
As an alternative, PFSF requested that the FDA require the drug’s manufacturers revise the safety information on the labeling and add boxed...
From the Journals
Biologic benefit in psoriasis might extend to arthritis prevention
People with psoriasis had a lower risk for psoriatic arthritis if they had been treated with a biologic than if they had not, based on a study of...
Feature
NIH to study COVID vaccine booster in people with autoimmune disease
The trial will look at the impact of a booster in patients with five different autoimmune diseases who are either on or off immunosuppressives.
News
FDA okays difelikefalin for dialysis-associated pruritus in patients with CKD
Pruritus in patients with chronic kidney disease on hemodialysis is common and has had no widely accepted go-to treatment.